UNITED THERAPEUTICS CORP (UTHR) Stock Cash Flow
NASDAQ:UTHR • US91307C1027
Current stock price
524.28 USD
-2.72 (-0.52%)
At close:
524.28 USD
0 (0%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 1.33B | 1.20B | 984.80M | 727.30M | 475.80M | |||
| Depreciation Amortization | 85.60M | 72.50M | 53.20M | 51.30M | 49.90M | |||
| Income Taxes - Deferred | 97.70M | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -106.50M | -60.20M | -97.80M | -141.20M | -174.20M | |||
| Interest Paid | 13.50M | 40.20M | 56.00M | 29.10M | 16.20M | |||
| Taxes Paid | 313.30M | 400.60M | 332.50M | 275.70M | 153.30M | |||
| Other non cash items | 149.70M | 119.70M | 37.80M | 165.10M | 246.70M | |||
| OPERATING CASH FLOW | 1.56B | 1.33B | 978.00M | 802.50M | 598.20M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -526.00M | -246.50M | -230.40M | -138.80M | -120.80M | |||
| Other Investing Activity | -25.30M | 663.70M | -489.20M | -672.70M | -366.10M | |||
| INVESTING CASH FLOW | -551.30M | 417.20M | -719.60M | -811.50M | -486.90M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -300.00M | -400.00M | -100.00M | 0.00 | 0.00 | |||
| Stock Issued/Repurchased | -816.90M | -839.90M | 104.60M | 94.30M | 55.60M | |||
| Other Financing Activity | -33.10M | -14.90M | -16.50M | -18.90M | -10.80M | |||
| FINANCING CASH FLOW | -1.15B | -1.25B | -11.90M | 75.40M | 44.80M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | -140.10M | 489.50M | 246.50M | 66.40M | 156.10M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 1.56B | 1.33B | 978.00M | 802.50M | 598.20M | |||
| Capital Expenditure | -526.00M | -246.50M | -230.40M | -138.80M | -120.80M | |||
| FREE CASH FLOW | 1.04B | 1.08B | 747.60M | 663.70M | 477.40M | |||
All data in USD